Skip to content
★ Sign in to follow
TF

Thomas F. Kearns Jr.

Board Director
Director
Total declarations
35
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (18 ops.)
€4.0M

Latest filing published 17 Sept 2021 for KYNTRA BIO, INC., €128k.

Filing timeline

BuySale
Thomas F. Kearns Jr.

Insider track record

Disclosed buys
0
Disclosed sells
18
Signal history

Thomas F. Kearns Jr.: trading record in brief

This profile gathers the share dealings of Thomas F. Kearns Jr. across 2 companies, led by Kyntra Bio, Inc. and Biomet Inc. Over a trading history stretching from 4 January 2006 to 15 September 2021, the count stands at 35 filings.

No open-market purchase appears, only 18 sales worth €4.0M. Outside the open market, there are 5 share grants and 8 option exercises. In 2021 alone, the filings show no purchases and 2 sales.

On 17 September 2021 came the latest disclosure, an open-market sale for €128k in Kyntra Bio, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Thomas F. Kearns Jr.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations34 total

25 of 34 declarations